aBSTRaCT OBJECTıvE: Cardiovascular diseases are the most common cause of death in patients with endstage renal disease. Asymmetrical dimethylarginine (ADMA) is increased in conditions associated with increased risk of atherosclerosis. We aimed to examine the association between severity of coronary stenosis and the ADMA levels in a group of chronic kidney disease (CKD) stage 1 to 3. maTERıal and mETHOdS: Eighty-eight (88) consecutive patients with decreased renal function (glomerular filtration rate (GFR) between 90 and 30 ml/min), undergoing cardiac catheterization for proven or clinically suspected coronary artery disease were enrolled at the study. Serum levels of creatinine, ADMA, nitric oxide (NO), calcium, phosphate, total cholesterol, HDL and LDL fractions, triglycerides were determined using measurement techniques. The Gensini scoring system was used for the detection of the severity of coronary atherosclerosis.
Nitric oxide is the most important molecule as it regulates the functions of the endothelium and represents the health of endothelial function. Endothelial dysfunction due to the reduced bioavailability of nitric oxide (NO) is involved in the course of atherosclerotic cardiovascular disease. NO is synthesized from L-arginine via the action of NO synthase (3) . Asymmetrical dimethylarginine (ADMA) is an endogenous inhibitor of endothelial nitric oxide synthase. ADMA may contribute to endothelial dysfunction. ADMA is produced in human cell during proteolysis of methylated nuclear proteins and is mainly metabolized by dimethylarginine dimethylaminohydrolase (4) . ADMA is increased in conditions associated with an increased risk of atherosclerosis, such as hypertension, hyperhomocysteinemia, impaired renal function, hypercholesterolemia, insulin resistance and diabetes mellitus (5) (6) (7) (8) (9) (10) (11) . ADMA may participate actively in development of atherogenesis in patients with end-stage renal disease. Additionally, the plasma level of ADMA is a strong predictor of progression of renal dysfunction in patients with chronic kidney disease (12) .
The multicentric CARDİAC study showed that manifestations of cardiovascular diseases were concomitant with high plasma concentrations of ADMA. ADMA may be a new marker for cardiovascular disease (13) .
Deterioration of kidney function is accompanied by mineral metabolism disturbances (increased phosphorus and parathyroid hormone) that have been linked to the increased cardiovascular morbidity and mortality seen in these patients, possibly via coronary calcification (14) .
In the present study, we aimed to examine the association between mineral metabolism levels (Ca, P, CaxP), ADMA, nitric oxide (NO) and the severity of coronary artery disease in a group of chronic kidney disease (CKD) patients (GFR between 90 and 30 ml/min/1.73m 2 ).
mETHOdS
A total of 212 consecutive patients undergoing cardiac catheterization for proven or clinically suspected coronary artery disease were collected for the study between November 2008 and March 2009. Eighty-eight (88) patients were included in the study. Exclusion criteria included the following: calculated GFR > 90 ml/min/1.73 m 2 or GFR < 30 ml/min/1.73 m 2 , patients with severe congestive heart failure (NYHA class III -IV), myocardial infarction, valvular heart disease, presence of coronary artery bypass graft surgery history, hepatic dysfunction, diabetes mellitus, the use of calcium supplements or vitamin D treatment. A total of 124 patients were excluded from the study: 42 patients had GFR≥ 90 ml/min/1.73 m², 3 patients had GFR ≤ 30 ml/min/1.73 m² and 20 patients were on dialysis; 11 patients had a positive history for coronary artery by-pass graft surgery; 9 patients had class IV congestive heart failure, and 48 patients were diagnosed with diabetes mellitus. The study was approved by the ethics committee.
All patients in the study underwent selective coronary artery angiography (Philips Allura Xper FD10) after appropriate patient preparation. Femoral artery cannulation was used for arterial access site and the Judkins system was applied for cannulation the left and right coronary arteries. All angiograms were evaluated by two experienced physicians blinded to the study. Angiograms with a stenotic lesion in all major epicardial coronary arteries including the left main, left anterior descending (LAD), left circumflex (LCx), and right coronary (RCA) arteries were evaluated and the severity of coronary artery disease was assessed by using the Gensini scoring system (15) .
The glomerular filtration rate was used for the detection of renal functional status. This parameter might be calculated by different methods. Although collected 24-hour urine sample is widely used for the calculation (Cockcroft-Gault equation), we chose a simpler method, which does not contain 24-hour urine sampling in the present study: GFR (ml/min) = (140-age [years]) X body weight (kg)/ plasma creatinine X 72. For female patients, the obtained value was multiplied by 0.85.
Blood samples were collected on the morning of the procedure after a 12-hour fasting period, and then stored and analyzed by the laboratory. We collected blood samples before angiography to perform ADMA, nitric oxide and all other analyses (glucose, lipoprotein profile, uric acid, serum creatinine).
Serum concentrations of ADMA were measured by immunochemical quantification, the ELISA method (kit, ADMA® ELISA, DLD Diagnostika GmbH, Hamburg) (16).
Nitric oxide was measured by chemiluminescence with a Sievers Nitric Oxide Analyzer, model 280 (Boulder, Colorado). Blood samples were cen-trifuged at 2500 rpm for 20 minutes at 10 °C. The supernatant was removed and stored at -70 C. The nitric oxide assay was standardized by a calibration curve using known concentrations of nitrate (0.01 to 100 jLtmol/L) obtained from sodium nitrate. For each measurement, a 4 JLLL sample was placed in a reducing vessel with 5 mL of 0.1 mole vanadium III chloride per L, 1 mole of hydrochloric acid per L, and 100 JLLL of antifoaming agent (Sievers) at 90 °C. Each standard was analyzed three times, and each plasma sample was analyzed at least five times. The mean value was used for all subsequent analysis.
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Statistical analysis
Data were analyzed using the SSPS 15.0 for Windows software (SPSS ® Inc. Chicago IL). All data are presented as mean ± standard deviation (SD) unless stated otherwise in the text. Continuous variables were checked for the normal distribution assumption using the Kolmogorov-Smirnov statistics and those that did not satisfy the criteria were logtransformed to attain normal distribution. The study group was divided into three subgroups based on the Gensini score tertiles. Correlations between two continuous variables were assessed using the t-test. The ANOVA test was used for multiple group comparisons of normally distributed variables. Chi square was used to test differences in frequency distributions. All potential (physiologically meaningful) determinants of the Gensini score were investigated in a univariate screening procedure, using the Pearson's coefficient of correlation test. Significant determinants identified from these analyses were studied in a multiple regression model using the F statistic. P<0.05 was considered as statistically significant for the final model. The KruskalWallis test was applied to assess the distribution of continuous variables. A two-tailed p-value of < 0.05 was considered to be statistically significant.
RESulTS
A total of 88 patients that satisfied the selection criteria was included in the analysis. The mean age in the study group was 42.5 ± 11.9 years; 64 % were men, 61.3% were hypertensive, and 28.3% were smokers.
Baseline demographic and biological data of the entire study group are outlined in Table I . The mean serum lipid values, were 192 ± 37 mg/dl for total cholesterol, 120 ± 34 mg/dl for LDL cholesterol, 40 ± 10 mg/dl for HDL cholesterol, and 163 ± 90 mg/dl for triglycerides. The percentage of the study population with lipid abnormalities was 22.8% for hypercholesterolemia, 54% for high LDL cholesterol, 31% for low HDL cholesterol and 42% for hypertrigliceridemia.
The mean serum values were 81.48 ± 13.8 micromol/l for ADMA and 3.7 ± 1.7 mmol/L for NO. The mean Gensini score in the study group was 30.4 ± 40.1.
Gensini Score Subgroup analysis
All patients were classified into tertiles of Gensini score level to evaluate whether the Gensini score was associated with the severity of decreased renal function in the study. The demographic, laboratory and treatment characteristics of the three groups are outlined in Table II . The mean age in three subgroups according to tertiles of Gensini score was similar but patients in the highest tertile were younger (41.2 ± 11.6 years vs 42.7 ± 12.4 years in the second tertile, 43.7 ± 11.7 years in the first tertile, p > 0.05) Patients in the highest tertile had statistically significant lower GFR values (71.1 ± 10.9 ml/min/1.73 m 2 vs 77.7 ± 6.5 ml/min/1.73 m 2 in the first tertile and 73.0 ± 6.8 ml/min/1.73 m 2 in the second tertile; p for trend = 0.019)
No statistical significance was present between subgroups for measurement of total, -LDL,-HDL-cholesterols and triglyceride levels. Total cholesterol levels decreased in second and third tertile of patients possibly due to more aggressive statin treatment. The mean values of triglycerides were abnormal in all subgroups.
There was a statistically higher incidence of hypertension in the third tertile of the Gensini score (p for trend = 0.008). The use of angiotensin converting enzime inhibitors, beta-blockers and diuretics was also statistically significantly higher in the third tertile compared with the first tertile of the Gensini score (p for trend 0.018 and 0.01 and 0.019) Across the Gensini tertiles, the ADMA values increased statistically significant in the third tertile compared with the first tertile (89.7 ± 14.3 micromol/l vs 74.9 ± 10.11 micromol/l; p for trend = 0.0001) and NO values decreased significantly in the third tertile as compared to the patients in the first and second tertiles (3.2 ± 1.5 vs 3.7 ± 1.2 and 4.1 ± 2.1mmol/L; p for trend = 0.05).
The Gensini score values significantly correlated with the glomerular filtration rate (R = -0.343, P 0 0.001); ADMA (R = 0.531, P = 0.000); and the presence of hypertension (R = 0.298, P = 0.005) but not with the NO values; the Ca, P, Ca×P, LDL cholesterol and smoking (Table III) in univariate analysis.
In a multivariate regression model, we introduced the metabolism parameters and the factors considered to influence coronary artery disease: the Ca, P, Ca×P product, NO, ADMA and GFR. In this step, ADMA (B= 0.340; p= 0.007) was the only statistically significant independent predictor of Gensini score (Table IV) .
We adjusted for the presence of the traditional risk factors (hypertension, smoking, lipid profile and gender) and GFR. Even after these adjustments, the ADMA (B= 1.131; p= 0.001) and the presence of hypertension (B= 24.8; p= 0.01) remained statistically significantly predictors of the Gensini score but not with the total cholesterol (B= 0.05; p= 0.7), HDL cholesterol (B= 0.04; p= 0.9), triglyceride (B= -0.04; p= 0.5), gender (B=19.2; p= 0.08), and smoking (B= 10; p= 0.3).
dıSCuSSıOn
Survival of patients with renal functional impairments is low because of increased risk of death from cardiovascular causes. Cardiovascular mortality in end-stage renal disease (ESRD) and GFR -glomerular filtration rate; ldl cholesterol -low density lipoprotein cholesterol; Hdl cholesterol -high density lipoprotein cholesterol; aCE -angiotensin conversion enzyme; aRB -angiotensin receptor blockers; adma, asymmetrical dimethylarginine; nO, nitric oxide
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predialysis CKD patients is increased and not entirely explained by traditional risk factors (17) .
In this cross-sectional study of patients with CKD 1-3 not yet on dialysis, we report a significant association between elevated levels of ADMA and increased coronary artery lesions as objectively assessed by coronary angiography. Moreover, this association remained statistically significant after adjustment for established cardiovascular risk factors such as gender, lipid profile, smoking, hypertension and GFR. Besides, determinants of the mineral metabolism in CKD patients (serum Ca, P, Ca×P product) were not found to be statistically significant predictors of the Gensini score of coronary lesions in multivariate analysis.
Though the prevalence of traditional Framingham risk factors (such as hypertension, diabetes mellitus, dyslipidemia, smoking) is very high in patients with renal impairment, non-traditional risk factors such as inflammation and oxidative stress, which are observed frequently in renal failure causing atherosclerosis, have also been investigated (1, 18) . In our study, this was directly correlated to CAD severity in the general population as regards the presence of hypertension. The presence of hypertension remained a statistically significant predictor of the Gensini score in multivariate analysis.
Gradaus et al. have demonstrated that a more rapid progression of coronary stenosis in patients with ESRD is present compared to patients with normal renal function (19 (20) .
The calculated GFR correlated with the Gensini score with univariate analysis in our study. GFR had emerged as an important predictor for the risk of severity for CAD in a previous study. However, the GFR did not reach statistical significance as an Coronary artery calcification correlates with the extent of coronary artery atherosclerosis, occurring more frequently in uremic patients. Strong relationships between increased serum phosphate, calcium-phosphate product, parathyroid hormone, and mortality from cardiovascular causes have recently been demonstrated. Clinical studies have shown that serum Ca and P are normal until GFR < 40 ml/min (21). Similarly, there were minimal abnormalities in serum Ca, P levels and the Ca×P product in our study. We also found no correlation between the Ca and P levels and Ca×P product and the Gensini score values on univariate analysis and they did not emerge as independent predictors of CAD on multivariate analysis.
NO is a cardiovascular protective substance because it causes vasodilation and leucocyte aggregation. NO inhibition by ADMA may therefore be relevant as a pro-atherogenic mechanism (12). Miyazaki et al. have demonstrated that intima-media thickness is strongly related to plasma ADMA in apparently healthy subjects, indicating that this substance is an early marker of atherosclerosis (22) . The CARDIAC study showed that the ADMA may be a causal factor in the initiation and progression of ischemic vascular disease (13) . ADMA predicts death, cardiovascular complications and progression of intimal lesions independently of other risk factors in ESDR patients (23) . The association between ADMA and survival has been very recently confirmed in patients with CKD in the predialysis phase (24, 25) . In our study the ADMA level was slightly elevated in the first two tertiles of the Gensini score but increased significantly in patients in the third tertile. The association with the Gensini score was present in univariate analysis and maintained in multivariate analysis after adjustment for traditional risk factors, NO and GFR. The data suggests that the ADMA levels can reflect a possible independent role in CAD pathogenesis.
There are several limitations in our study: first, we believe that it is limited in the number of study population. Second, our study did not include diabetic patients and we cannot postulate that the only link would be through an insulin resistance mechanism.
In conclusion, ADMA in patients with mild to moderate CKD is an independent prognostic factor for coronary artery disease extent.
